006280 — GC Biopharma Share News
0.000.00%
Last trade - 00:00- KR₩2tn
- KR₩2tn
- KR₩2tn
Asia offers more flu shots to head off COVID-19 complications
S.Korea approves phase II human trial for Green Cross's coronavirus treatment drug
S.Korea's Green Cross seeks phase 2 trials of COVID-19 plasma drug
Spanish pharma Grifols buys plasma assets from Green Cross for $460 mln
Brief: Green Cross to pay cash dividend at 1,250 won/share
Brief: Green Cross says annual cash dividend for FY 2016
Brief: Green Cross signs contract worth $60 mln
Rlpc: Bain agrees 230 mln stg buyout of Plasma Resources UK (updated)
Rlpc: Bain agrees 200 mln stg buyout of Plasma Resources UK -source
S.Korea's Green Cross considers buying UK's Plasma Resources
S.Korea's Green Cross considers buying UK's Plasma Resources